- Home
- RANI vs CRIS Comparison
RANI vs CRIS Comparison
Compare RANI & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RANI
- CRIS
- Stock Information
- Founded
- RANI 2012
- CRIS 2000
- Country
- RANI United States
- CRIS United States
- Employees
- RANI N/A
- CRIS N/A
- Industry
- RANI Medicinal Chemicals and Botanical Products
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RANI Health Care
- CRIS Health Care
- Exchange
- RANI Nasdaq
- CRIS Nasdaq
- Market Cap
- RANI 23.2M
- CRIS 22.9M
- IPO Year
- RANI 2021
- CRIS 2000
- Fundamental
- Price
- RANI $0.50
- CRIS $1.68
- Analyst Decision
- RANI Strong Buy
- CRIS Strong Buy
- Analyst Count
- RANI 4
- CRIS 2
- Target Price
- RANI $7.75
- CRIS $16.50
- AVG Volume (30 Days)
- RANI 677.7K
- CRIS 72.4K
- Earning Date
- RANI 08-07-2025
- CRIS 08-05-2025
- Dividend Yield
- RANI N/A
- CRIS N/A
- EPS Growth
- RANI N/A
- CRIS N/A
- EPS
- RANI N/A
- CRIS N/A
- Revenue
- RANI $1,200,000.00
- CRIS $11,405,000.00
- Revenue This Year
- RANI N/A
- CRIS $1.41
- Revenue Next Year
- RANI N/A
- CRIS $7.46
- P/E Ratio
- RANI N/A
- CRIS N/A
- Revenue Growth
- RANI N/A
- CRIS 12.24
- 52 Week Low
- RANI $0.39
- CRIS $1.02
- 52 Week High
- RANI $3.75
- CRIS $6.44
- Technical
- Relative Strength Index (RSI)
- RANI 45.69
- CRIS 48.15
- Support Level
- RANI $0.44
- CRIS $1.63
- Resistance Level
- RANI $0.58
- CRIS $1.95
- Average True Range (ATR)
- RANI 0.04
- CRIS 0.14
- MACD
- RANI -0.01
- CRIS 0.02
- Stochastic Oscillator
- RANI 32.74
- CRIS 43.75
About RANI Rani Therapeutics Holdings Inc.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.